News and Trends 25 Nov 2024
Evotec on the brink of acquisition: At what cost for the biotech industry?
…update titled: “Challenging year; priority reset for sustainable profitable growth gaining momentum, building on core strengths.” The year was challenging indeed, with the revenues for shared research and development (R&D)…